Mylan launches generic Brevibloc heart injection

Mylan (NSDQ:MYL) said today that it launched a generic version of Baxter‘s (NYSE:BAX) Brevibloc heart drug in the U.S.

The company’s injectable product, esmolol hydrochloride in sodium chloride, will be offered in single-dose plastic bags, according to Mylan.

Get the full story at our sister site, Drug Delivery Business News.

The post Mylan launches generic Brevibloc heart injection appeared first on MassDevice.

from MassDevice https://ift.tt/2xaOSak